UNSPSC 85621708: Insertion of infusion device into endocrine gland, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of infusion device into endocrine gland, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0GHS43Z

UNSPSC 85621708 Insertion of infusion device into endocrine gland, percutaneous endoscopic approach is a Commodity code showing little relevant recent activity. The recent opportunities posted under this code — a disability medical evaluation RFP from Phoenix, a surgical benefits carve-out RFP from Long Beach, an occupational medical surveillance RFP from Washington State Ferries, a juvenile detention emergency medical services RFI from Harris County, a pharmacy benefit management RFP from Collier County, and a temporary health professional staffing pool from Santa Clara Health System — do not align with the code's narrowly specified clinical scope. None of these solicitations requests infusion device insertion services, percutaneous endoscopic procedures, or endocrine gland interventions. The code appears to have been applied inconsistently or as a placeholder in state and local procurement systems.

State and local procurement offices rarely solicit specialized endocrine procedures directly; such services are typically procured through health plan networks, provider contracts, or hospital service agreements rather than standalone procedure-level RFPs. The mismatch between the code's clinical specificity and the actual scope of recent opportunities suggests either tagging drift in the procurement database or that this Commodity code does not reflect current purchasing patterns in state and local government. Firms pursuing work in occupational health, medical surveillance, or temporary clinical staffing may see their opportunities tagged under this code, but the code itself does not predict procurement activity in endocrine interventions.